2026 American Academy of Dermatology Annual Meeting

AAD 2026 Late-Breaking Presentation Details Title: Vilobelimab Treatment for Ulcerative Pyoderma Gangrenosum: Results from a Multicenter, Randomized, Placebo Controlled Phase 3 Trial

Session Type: Oral presentation
Presenter: Benjamin Kaffenberger, MD
Time: March 28, 2026, 2:24-2:36 PM MT
Location: Bellco Theatre 3